Tomorrow AAAS Fellow, Robert C. von Borstel will talk about how cancer cell mutation and selection are metaphorically similar to the evolution of a new species.Like the first pregnant finch that landed in the Galapagos, the first cancer cell in a body has to undergo many mutations through many generations to establish itself. But once there, like any newly stabilized species in different ecological niches, cancer is tough to get rid of.
A new class of targeted anti-cancer drugs that blocks the human epidermal growth factor (HER) receptor family shows promise in prolonging the lives of patients with recurrent prostate cancer, a new Cedars-Sinai study shows.
Imagine a cancer treatment tailored to the cells in a patient?s body, each person receiving a unique treatment program.
A team of researchers, led by academics from UNSW and St Vincent’s Hospital, have made a discovery that transforms our understanding of genetic diseases.
Group exercise sessions can help to improve the physical and psychological wellbeing of people diagnosed with breast cancer, a new BMJ study reveals today.
Caring for a partner with cancer may be one of the most testing and stressful experiences a person can have during their lifetime. An unspoken casualty of the cancer diagnosis can often be the loss of sex and intimacy between couples.
Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online.
Two major research organizations in the Phoenix area have announced they will collaborate on an ambitious goal: Creating a vaccine to prevent the development of cancer. Researchers at the Biodesign Institute at Arizona State University (ASU) in Tempe and Mayo Clinic will use the latest developments in laboratory and clinical sciences to reach their goal — finding components in cancer that could be used to vaccinate against the occurrence of the disease.
AstraZeneca has pledged USD$10 million to help fund 50 new American Cancer Society Patient Navigator Program sites over the next five years in communities throughout the United States. The Patient Navigator Program is an initiative to assist individual cancer patients in negotiating the health care system.
A featured paper in the February 14 issue of Nature Cancer Gene Therapy demonstrates that cancer cells in the liver are excellent targets for gene therapy using adenoviral vectors, based upon a fundamental new understanding of the differences between cancerous and normal liver cells.